Legato Capital Management LLC Acadia Pharmaceuticals Inc Transaction History

Legato Capital Management LLC

  • $761 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024
BUY
$20.78 - $31.77 $136,670 - $208,951
6,577 New
6,577 $205,000
Q1 2018

Apr 19, 2018
SELL
$22.47 - $32.33 $661,337 - $951,536
-29,432 Closed
0 $0
Q4 2017

Jan 24, 2018
SELL
$26.84 - $39.14 $115,841 - $168,928
-4,316 Reduced 12.79%
29,432 $886,000
Q3 2017

Oct 31, 2017
BUY
$29.49 - $38.37 $995,228 - $1.29 Million
33,748
33,748 $1.27 Million

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email